Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Thyroid Nodule clinical trials

5 of 6 indexed Thyroid Nodule trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Thyroid Nodule: 6 US clinical trials tracked, 5 recruiting.

Thyroid Nodule is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Stony Brook University, running 1 of these trials.

Enrollment posture brief

Registry condition thyroid-nodule

OPEN 5 | RECR 83% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

Thyroid Nodule (this)83%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Thyroid Nodule

Thyroid Nodule lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thyroid Nodule on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thyroid Nodule is recruiting above its size-band peers.

    5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Thyroid Nodule research.

    Stony Brook University accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Thyroid Nodule trials plan to enrol fewer than 100 people.

    Median target enrolment is 85 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Thyroid Nodule research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Thyroid Nodule records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Shear-Wave Elastography Device
1 trials
Thyroid Nodule Management Education Behavioral
1 trials
Active Monitoring Procedure
1 trials
nPulse Vybrance Percutaneous Electrode System Device
1 trials
Multiparametric ultrasound (mpUS) imaging Diagnostic test
1 trials
Mygen V-1000 RF system Device
1 trials
Biopsy Procedure
1 trials

US sites by state

Facility locations filed on Thyroid Nodule trials. A trial with sites in several states counts in each.

New York 4 trials
New Jersey 1 trials
New Hampshire 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thyroid Nodule page

6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thyroid Nodule condition card totals 6 registered trials; most-linked intervention Shear-Wave Elastography; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.